How is the Alaunos Therapeutics Inc today?

The Alaunos Therapeutics Inc today is trading in the green, up by 0.71% at 2.84.

What is Alaunos Therapeutics Inc Annual Revenue?

Alaunos Therapeutics Inc Annual Revenue rose 100%, in the last year to $0.01 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Alaunos Therapeutics Inc Annual Net Profit?

Alaunos Therapeutics Inc Annual Net Profit rose 86.68% in the last year to $4.68 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Alaunos Therapeutics Inc Price to Earning Ratio?

Alaunos Therapeutics Inc Price to Earning Ratio is -0.99, which is negative.

What is Alaunos Therapeutics Inc Stock Price?

Alaunos Therapeutics Inc Stock Price rose 132.79% and outperformed its sector by 123.93% in the past year.

What is Alaunos Therapeutics Inc Quarterly Net profit?

Alaunos Therapeutics Inc Quarterly Net profit rose 90.54% YoY to $0.74 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Alaunos Therapeutics Inc Return on Equity(ROE)?

Alaunos Therapeutics Inc Return on Equity(ROE) for the last financial year was -111.8%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Alaunos Therapeutics Inc Mutual Fund Holding?

Alaunos Therapeutics Inc Mutual Fund Holding decreased by 0.04% in the last quarter to 5.95.

What is Alaunos Therapeutics Inc Promoter Share Holding?

Alaunos Therapeutics Inc Promoter Share Holding decreased by 0.56% in the most recent quarter to 0.37%.

What is Alaunos Therapeutics Inc Institutional Holding?

Alaunos Therapeutics Inc Institutional Holding decreased by 0.1% in the last quarter to 12.26.

Alaunos Therapeutics Inc XNAS: TCRT

Alaunos Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Alaunos Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Alaunos Therapeutics Inc
Rating: 1.65266675
Author: Trendlyne DVM scores

about

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising ...

2.84 0.02 (0.71%)

49.47% Fall from 52W High

4,268 XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

7.7 / 100

Technically Neutral

58.4 / 100

No estimates available

Alaunos Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Alaunos Therapeutics Inc FAQ

How is Alaunos Therapeutics Inc today?

Alaunos Therapeutics Inc today is trading in the green, and is up by 0.71% at 2.84.

How has Alaunos Therapeutics Inc performed historically?

Alaunos Therapeutics Inc is currently trading up 0.71% on an intraday basis. In the past week the stock fell -0.35%. stock has been up 75.31% in the past quarter and rose 132.79% in the past year. You can view this in the overview section.